Literature DB >> 26712072

Clinical problems in patient with Ehlers-Danlos syndrome and Multiple Chemical Sensitivity undergoing total thyroidectomy.

V Pasta, V D'Orazi, L Ruggeri, M F Toni, P Urciuoli, G Tellan.   

Abstract

Clinical practice sometimes brings to face with situations quite peculiar, potentially dangerous for the patient's life. In the great majority of cases, pathologies associated with each other (cardiovascular, respiratory, neurological), while in other cases we can treat rare diseases or syndromes. It's considered exceptional the simultaneous presence of "rare" pathologies in a single patient. This exceptionality has been a push to treat a patient as a "unique" asking for help to deeper studies of pharmacogenetics. Our case reports the management of a patient with Ehlers-Danlos syndrome (EDS) and Multiple Chemical Sensitivity (MCS), undergoing a total thyroidectomy. We found several problems, and we tried to find effective solutions for the management of the patient during the whole peri-operative process, from a clinical, pharmacological and also from a surgical point of view.

Entities:  

Mesh:

Year:  2015        PMID: 26712072      PMCID: PMC4732587          DOI: 10.11138/gchir/2015.36.4.168

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  11 in total

1.  The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS).

Authors:  R Grahame; H A Bird; A Child
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

2.  Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR.

Authors:  Gail McKeown-Eyssen; Cornelia Baines; David E C Cole; Nicole Riley; Rachel F Tyndale; Lynn Marshall; Vartouhi Jazmaji
Journal:  Int J Epidemiol       Date:  2004-07-15       Impact factor: 7.196

3.  Ehlers-Danlos syndrome: complications and solutions concerning anesthetic management.

Authors:  Barrett A Johnston; Kaitlin E Occhipinti; Amir Baluch; Alan D Kaye
Journal:  Middle East J Anaesthesiol       Date:  2006-10

4.  Multifactorial index of cardiac risk in noncardiac surgical procedures.

Authors:  L Goldman; D L Caldera; S R Nussbaum; F S Southwick; D Krogstad; B Murray; D S Burke; T A O'Malley; A H Goroll; C H Caplan; J Nolan; B Carabello; E E Slater
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

5.  Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes.

Authors:  Chiara De Luca; Maria G Scordo; Eleonora Cesareo; Saveria Pastore; Serena Mariani; Gianluca Maiani; Andrea Stancato; Beatrice Loreti; Giuseppe Valacchi; Carla Lubrano; Desanka Raskovic; Luigia De Padova; Giuseppe Genovesi; Liudmila G Korkina
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-27       Impact factor: 4.219

Review 6.  Neuropsychiatric and somatic characteristics of young adults with and without self-reported chemical odor intolerance and chemical sensitivity.

Authors:  I R Bell; C S Miller; G E Schwartz; J M Peterson; D Amend
Journal:  Arch Environ Health       Date:  1996 Jan-Feb

Review 7.  Behavioral treatment of phobic avoidance in multiple chemical sensitivity.

Authors:  R S Guglielmi; D J Cox; D A Spyker
Journal:  J Behav Ther Exp Psychiatry       Date:  1994-09

8.  Quality of life and health-services utilization in a population-based sample of military personnel reporting multiple chemical sensitivities.

Authors:  D W Black; B N Doebbeling; M D Voelker; W R Clarke; R F Woolson; D H Barrett; D A Schwartz
Journal:  J Occup Environ Med       Date:  1999-10       Impact factor: 2.162

Review 9.  Mechanisms of allergy and chemical sensitivity.

Authors:  W J Meggs
Journal:  Toxicol Ind Health       Date:  1999 Apr-Jun       Impact factor: 2.273

Review 10.  Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome(s).

Authors:  Thomas Wiesmann; Marco Castori; Fransiska Malfait; Hinnerk Wulf
Journal:  Orphanet J Rare Dis       Date:  2014-07-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.